(Q64050925)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24408225%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

title

Rituximab fails where eculizumab restores renal function in C3nef-related DDD (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24408225%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24408225%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

Caroline Rousset-Rouvière

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24408225%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Mathilde Cailliez

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24408225%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Florentine Garaix

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24408225%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Daniele Bruno

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24408225%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Daniel Laurent

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24408225%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

language of work or name

English

0 references

publication date

10 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24408225%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24408225%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24408225%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24408225%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

1107-1111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24408225%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00467-013-2711-5

4 March 2020

exact match

0 references

cites work

Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis

1 reference

12 December 2020

Autoimmune forms of thrombotic microangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles

1 reference

12 December 2020

Eculizumab in a patient with dense-deposit disease

1 reference

12 December 2020

Membranoproliferative glomerulonephritis with C3NeF and genetic complement dysregulation

1 reference

12 December 2020

Recurrent dense deposit disease after renal transplantation: an emerging role for complementary therapies

1 reference

12 December 2020

Eculizumab for dense deposit disease and C3 glomerulonephritis

1 reference

12 December 2020

Factor H autoantibodies in membranoproliferative glomerulonephritis.

1 reference

12 December 2020

C3 deposition glomerulopathy due to a functional factor H defect

1 reference

12 December 2020

Eculizumab for the Treatment of Dense-Deposit Disease

1 reference

12 December 2020

Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement

1 reference

12 December 2020

Pathology after eculizumab in dense deposit disease and C3 GN.

1 reference

12 December 2020

Eculizumab for congenital atypical hemolytic-uremic syndrome.

1 reference

12 December 2020

C3 glomerulopathy: a new classification

1 reference

12 December 2020

Rituximab therapy for Type I membranoproliferative glomerulonephritis.

1 reference

12 December 2020

Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies

1 reference

12 December 2020

Treatment options for C3 glomerulopathy

1 reference

12 December 2020

Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies

1 reference

12 December 2020

Recurrence of membranoproliferative glomerulonephritis type II in renal allografts: The North American Pediatric Renal Transplant Cooperative Study experience

1 reference

12 December 2020

Eculizumab and recurrent C3 glomerulonephritis

1 reference

12 December 2020

The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria

1 reference

12 December 2020

Eculizumab and Refractory Membranoproliferative Glomerulonephritis

1 reference

12 December 2020

[Role of monoclonal antibodies in the treatment of immune-mediated kidney disease: the state of the art].

1 reference

12 December 2020

Clinical features and outcomes of 98 children and adults with dense deposit disease.

1 reference

12 December 2020

Allograft failure in kidney transplant recipients with membranoproliferative glomerulonephritis

1 reference

12 December 2020